NEW YORK (GenomeWeb News) – ILS announced on Friday it has acquired the Morrisville, N.C. site of Beckman Coulter Genomics and formed ILS Genomics.

ILS Genomics provides services in genotyping and gene expression, as well as biologics product safety testing. Sam Tetlow, chief business officer for ILS, was named general manager of ILS Genomics.

The company said that it has capabilities in key platforms for gene expression profiling, including Affymetrix, Illumina, Agilent, Sequenom, and Life Technologies business Applied Biosystems.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.